Cancer is a worldwide pandemic. The burden it imposes grows steadily on a global scale
causing emotional, physical, and financial strains on individuals, families, and health care …

The minimally—or non-invasive detection of circulating tumor-derived components in
biofluids, such as blood, liquid biopsy is a revolutionary approach with significant potential …

Cancer patients benefit from early tumor detection since treatment outcomes are more
favorable for less advanced cancers. Platelets are involved in cancer progression and are …

Glioblastoma multiforme (GBM) is the most frequent and deadly human brain cancer. Early
diagnosis through non-invasive biomarkers may render GBM more easily treatable …

Glioblastoma (GBM) is the most common primary tumor of the central nervous system.
Arising from neuroepithelial glial cells, GBM is characterized by invasive behavior, extensive …

Simple Summary Minimal residual disease (MRD) represents a status of the disease which
is assumed to still be present in the body until it is clinically observed by radiology. At this …

Simple Summary Interaction between blood platelets and cancer cells play an important role
in various steps of cancer development and progression. These interactions lead to changes …

In recent years, liquid biopsy has emerged as an alternative method to diagnose and
monitor tumors. Compared to classical tissue biopsy procedures, liquid biopsy facilitates the …

Nucleic acids and proteins are shed into the bloodstream by tumor cells and can be
exploited as biomarkers for the detection of cancer. In addition, cancer detection biomarkers …

Background Gliomas are the most common and aggressive tumors of the central nervous
system. A robust and widely used blood-based biomarker for glioma has not yet been …